iiinova — where your digital self keeps evolving

Reposted by Tempus AI

Yale Cancer Center @yalecancer.bsky.social · 08/07/2025

Dr. Frederick Wilson + colleagues have identified RASGRF1/2 fusions across a variety of tumor types, gaining insight on incidence, structural diversity, + tissue distribution of this distinct fusion class. 🔗 www.nature.com/articles/s41... @tempusai.bsky.social

nature.com

Genetic and oncogenic features of RASGRF fusions - npj Precision Oncology

npj Precision Oncology - Genetic and oncogenic features of RASGRF fusions

021

Tempus AI @tempusai.bsky.social · 21/05/2025

Looking forward to seeing you at #ASCO25! Attend our Industry Expert Theater with Kate Sasser, PhD, Ezra Cohen, MD, and Halla Nimeiri, MD, to discover how we are redefining precision oncology at scale—where our tests fuel smarter decisions and data advances care. Find more info: tempus.co/3S7WDYp

020

Tempus AI @tempusai.bsky.social · 20/05/2025

We’re excited to announce a collaboration to develop a companion diagnostic test with Verastem Oncology. Our FDA-approved xT CDx assay is being leveraged as an investigational assay in Verastem’s global Phase 3 RAMP-301 clinical trial. Read more: tempus.co/3H3F9Kw

010

Reposted by Tempus AI

Boehringer Ingelheim @boehringerglobal.bsky.social · 14/05/2025

#NEWS: We are joining forces with @tempusai.bsky.social By combining our experimental data with Tempus AI's real-world data on its AI-powered platform, we aim to pave the way for novel cancer treatments. Learn more: bit.ly/43owlqa #DataScience #Cancer #ResearchCollaboration

A young man shows a tablet screen to an older man. The headline says "Progressing cancer care." and on the bottom right "Life forward".

131

Tempus AI @tempusai.bsky.social · 09/05/2025

At #MIGlobal, Kate Sasser, PhD, our Chief Scientific Officer, participated in the "Accelerating a Healthier Future Through AI" panel." @milkeninstitute.org Watch the full recording here: milkeninstitute.org/content-hub/...

022

Tempus AI @tempusai.bsky.social · 14/02/2025

We're on-site at #GU25! Stop by Booth #30 to meet with our team, learn more about our research in genitourinary cancers and explore our latest advancements in tech and #AI.

010